However, it is much lower in patients with other connective tissue diseases, such as systemic lupus erythematous, Sjögren syndrome, or dermatomyositis, as up to a third of these patients may have positive cN-1A antibodies and not have IBM (47, 48). This evidence concerns the gene NT5C1A and dermatomyositis.